INS and Hypoglycemia: The insulin using group had longer duration of diabetes, higher HbA1c, history of severe hypoglycemia (all P < 0.001), and greater fear of hypoglycemia than the noninsulin using group (P < 0.001).33 Therefore, automated insulin delivery systems use in T2D present an excellent regimen modality to not only improve glucometrics, but also to reduce hypoglycemia regardless of the HbA1c levels.